| Announce Date | 10/01/2025 |
| EPS Normalized Actual | $-0.24 (Miss by $-0.02) |
| EPS GAAP Actual | $-0.24 (Miss by $-0.02) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2025 | 0 | INF | 0 | 0 | 0 |
| Dec 2024 | -0.7 | -0.88 | -0.7 | -0.7 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2024 (Mar 2024) | -0.19 | -0.19 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.19 | -0.19 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | -0.12 | -0.12 | 0.0001445B | 100% | 0.14M |
| FQ2 2025 (Jun 2025) | -0.12 | -0.12 | 0.0001445B | 100% | 0.14M |
| FQ4 2023 (Dec 2023) | -0.0135 | -0.0135 | 0B | NAN% | 0M |
| FQ3 2023 (Sep 2023) | -0.21 | -0.21 | 0B | NAN% | 0M |
| FQ2 2023 (Jun 2023) | -0.24 | -0.24 | 0B | NAN% | 0M |
| FQ1 2023 (Mar 2023) | -0.23 | -0.23 | 0B | NAN% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.12 | -- | 0.12 | 0.12 | 1 |
| FQ3 2028 (Sep 2028) | 0.12 | -- | 0.12 | 0.12 | 1 |
| FQ2 2028 (Jun 2028) | -0.03 | -- | -0.03 | -0.03 | 1 |
| FQ1 2028 (Mar 2028) | -0.19 | -- | -0.19 | -0.19 | 1 |
| FQ4 2027 (Dec 2027) | -0.22 | -- | -0.22 | -0.22 | 1 |
| FQ3 2027 (Sep 2027) | -0.16 | -- | -0.16 | -0.16 | 1 |
| FQ2 2027 (Jun 2027) | -0.54 | -- | -0.54 | -0.54 | 1 |
| FQ1 2027 (Mar 2027) | -0.29 | -- | -0.29 | -0.29 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ3 2028 (Sep 2028) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ2 2028 (Jun 2028) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ1 2028 (Mar 2028) | 0B | -- | 0B | 0B | 1 |
| FQ4 2027 (Dec 2027) | 0B | -- | 0B | 0B | 1 |
| FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 1 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 1 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
2
Revenue # of Misses
0
Revenue # of in-lines
6
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2024 (Mar 2024) | -0.19 | -0.19 | 100% | |
| FQ2 2024 (Jun 2024) | -0.19 | -0.19 | 100% | |
| FQ1 2025 (Mar 2025) | -0.12 | -0.12 | 100% | |
| FQ2 2025 (Jun 2025) | -0.12 | -0.12 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0135 | -0.0135 | 100% | |
| FQ3 2023 (Sep 2023) | -0.21 | -0.21 | 100% | |
| FQ2 2023 (Jun 2023) | -0.24 | -0.24 | 100% | |
| FQ1 2023 (Mar 2023) | -0.23 | -0.23 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0.14M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0.14M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
| FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |
| FQ2 2023 (Jun 2023) | $0B | $0B | $0M | NAN% |
| FQ1 2023 (Mar 2023) | $0B | $0B | $0M | NAN% |